Altria Group (MO) risk factors, FY2024 10-K

Altria Group's FY2024 10-K, filed Feb 26, 2025, lists 25 risk factors in 3 groups. There is no earlier 10-K to compare against, so the most company-specific risks are listed below.

Risk factors listed
253 groups
Section length
10k wordsItem 1A

Altria Group's biggest risks in the FY2024 10-K

  • Heavy reliance on premium brands like Marlboro, Copenhagen, and Skoal creates vulnerability to macroeconomic pressures and volume declines.

The risks most specific to Altria Group

  • Business Operations Risks

    We may be unsuccessful in anticipating and responding to changes in adult tobacco consumer preferences and purchase behavior, including as a result of difficult economic conditions, which could have a material adverse effect on our business, results of operations, cash flows or financial position

    Inflation and economic conditions may reduce adult consumer purchases of premium brands like Marlboro, Copenhagen, and Skoal.

  • Business Operations Risks

    Our inability to successfully counter the effects of illicit trade in tobacco products, including e-vapor products, could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision

    Illicit trade in tobacco and e-vapor products can reduce sales volumes for our traditional and smoke-free offerings.

  • Business Operations Risks

    In October 2024, we announced the multi-phase Initiative, through which we plan to increase our organization’s speed, efficiency and effectiveness by centralizing work, outsourcing certain transactional tasks and streamlining, automating and standardizing processes

    Our October 2024 Initiative to centralize work and outsource transactional tasks risks operational continuity and internal controls.

  • Business Operations Risks

    Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect our results of operations, cash flows or financial position and our ability to achieve our Vision

    Pending litigation and government investigations against our subsidiary PM USA and others could harm our financial position.

  • Business Operations Risks

    Disruption and uncertainty in the credit and capital markets could materially adversely affect our business

    We rely on the commercial paper market in the second quarter to fund Master Settlement Agreement payments, taxes, and dividends.

  • Risks Relating to Our Investments in Equity Securities

    The expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all, which could have a material adverse impact on our financial position or earnings

    Foreign currency rates, ABI share price, and ABI business results can impact the expected benefits of our investment in ABI.

  • Risks Relating to Our Investments in Equity Securities

    Our investment in Cronos subjects us to certain risks associated with Cronos’s business, including legal, regulatory and reputational risks

    Our investment in Canadian cannabinoid company Cronos exposes us to legal, regulatory, and reputational risks in the cannabis sector.

All 25 risk factors

Headings as the filing states them, in filing order.

Business Operations Risks

  1. 01We may be unsuccessful in anticipating and responding to changes in adult tobacco consumer preferences and purchase behavior, including as a result of difficult economic conditions, which could have a material adverse effect on our business, results of operations, cash flows or financial position
  2. 02The primary impacts of these conditions include higher than expected domestic cigarette industry volume declines and declines in pod-based product volume within the e-vapor category, which have negatively impacted our business
  3. 03We face significant competition, and our failure to compete effectively could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision
  4. 04Our inability to successfully counter the effects of illicit trade in tobacco products, including e-vapor products, could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision
  5. 05Failure to complete or manage strategic transactions, including acquisitions, dispositions, joint ventures and investments in third parties, or realize the anticipated benefits of such transactions, could have a material adverse effect on our business, financial position and our ability to achieve our Vision
  6. 06Significant changes in price, availability or quality of tobacco, other raw materials or component parts could have a material adverse effect on our profitability and business
  7. 07We may be required to write down goodwill and intangible assets, including trademarks and intellectual property, due to impairment, which could have a material adverse effect on our results of operations or financial position
  8. 08In October 2024, we announced the multi-phase Initiative, through which we plan to increase our organization’s speed, efficiency and effectiveness by centralizing work, outsourcing certain transactional tasks and streamlining, automating and standardizing processes
  9. 09We could decide, or be required to, recall products, which could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position
  10. 10We may be unable to attract and retain a highly skilled workforce due to the decreasing social acceptance of tobacco usage, tobacco control actions and other factors, which could have a material adverse effect on our business and our ability to achieve our Vision
  11. 11Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect our results of operations, cash flows or financial position and our ability to achieve our Vision
  12. 12Significant federal, state and local governmental actions, including FDA regulatory actions and inaction, and various private sector actions may continue to have a material adverse impact on our operating companies’ sales volumes and our business
  13. 13Tobacco products are subject to substantial taxation, and any increases in tobacco product-related taxes could have a material adverse impact on sales of our operating companies’ products
  14. 14International business operations subject us to various U.S. and foreign laws and regulations, and violations of such laws or regulations could result in reputational harm, legal challenges and significant penalties and other costs
  15. 15A challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws could materially adversely affect our earnings or cash flows
  16. 16Legal and regulatory requirements related to climate change and other environmental sustainability matters could have a material adverse impact on our business and results of operations
  17. 17Disruption and uncertainty in the credit and capital markets could materially adversely affect our business
  18. 18A downgrade or potential downgrade of our credit ratings could adversely impact our borrowing costs and access to credit and capital markets, which could materially adversely affect our financial condition
  19. 19Our performance relating to corporate responsibility matters and investor and stakeholder responses thereto may impact our reputation, ability to attract investors and the market value of our stock
  20. 20The failure of our, or our service providers’, key suppliers’ or trade customers’, information systems to function as intended, or cyber-attacks or security breaches, could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position
  21. 21protocols, backup systems and business continuity plans, maintenance of security policies and procedures, monitoring of networks and systems, and third-party risk management
  22. 22We and our service providers, key suppliers and trade customers are subject to a variety of continuously evolving and developing laws and regulations in numerous jurisdictions regarding personal data protection, privacy, artificial intelligence and information security

Risks Relating to Our Investments in Equity Securities

  1. 23The expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all, which could have a material adverse impact on our financial position or earnings
  2. 242020 and did not pay its interim 2020 dividend that would have been paid in the fourth quarter of 2020, which resulted in a reduction of cash dividends we received from ABI
  3. 25Our investment in Cronos subjects us to certain risks associated with Cronos’s business, including legal, regulatory and reputational risks

Other Altria Group 10-Ks

  • FY2025 10-K risk factors
    23 risks3 new5 dropped13 reworded

    Altria faces evolving consumer preferences driving cigarette volume declines and economic pressures shifting buyers toward discount brands. Packaging regulations targeting single-use plastics threaten supply costs and product availability. The Optimize & Accelerate initiative introduces business continuity and reporting risks from outsourcing.

    Filed Feb 25, 2026

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.